A propensity score matched comparison of different insulin regimens 1 year after beginning insulin in people with type 2 diabetes
暂无分享,去创建一个
[1] S Kamen,et al. The task force. , 1976, Journal of hospital dental practice.
[2] D. Rubin,et al. The central role of the propensity score in observational studies for causal effects , 1983 .
[3] R. Rubin,et al. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. , 2005, Diabetes care.
[4] H. Yki-Järvinen,et al. Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study , 2006, Diabetologia.
[5] Robert A Gabbay,et al. Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs. , 2005, Diabetes care.
[6] Idf Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care , 2006, Diabetic medicine : a journal of the British Diabetic Association.
[7] H. Rodbard,et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. , 2007, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[8] A. Farmer,et al. Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. , 2007, The New England journal of medicine.
[9] P. Sharplin,et al. Switching from premixed insulin to glargine-based insulin regimen improves glycaemic control in patients with type 1 or type 2 diabetes: a retrospective primary care-based analysis , 2009, Cardiovascular diabetology.
[10] P. Sharplin,et al. Improved glycaemic control by switching from insulin NPH to insulin glargine: a retrospective observational study , 2009, Cardiovascular diabetology.
[11] Jesse C. Crosson,et al. Barriers to Insulin Initiation , 2010, Diabetes Care.
[12] P. Home,et al. An observational non-interventional study of people with diabetes beginning or changed to insulin analogue therapy in non-Western countries: the A1chieve study. , 2011, Diabetes research and clinical practice.
[13] N. Freemantle,et al. Factors influencing initial choice of insulin therapy in a large international non-interventional study of people with type 2 diabetes , 2012, Diabetes, obesity & metabolism.
[14] S. Inzucchi,et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379 , 2013, Diabetes Care.
[15] Qian Rong-l,et al. A better comprehension of “Management of Hyperglycemia in Type 2 Diabetes:A Patient-Centered Approach—Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)” , 2013 .